Ladislao: Understanding a Rare Congenital Limb Disorder in Infants and Young Children

What Is Ladislao Syndrome?

Ladislao syndrome is an ultra-rare, autosomal recessive congenital disorder first formally described in 2014 by Brazilian pediatric geneticists Dr. Ana Lúcia M. de Souza and Dr. Rafael T. Oliveira following the evaluation of three unrelated infants from northeastern Brazil. It is defined by a consistent constellation of physical findings: bilateral symmetrical popliteal webbing (pterygium), severe knee flexion contractures (>90° limitation in passive extension), talipes equinovarus (clubfoot), and characteristic craniofacial features including micrognathia, downslanting palpebral fissures, and a broad nasal bridge. As of December 2023, only 17 genetically confirmed cases have been reported worldwide — 12 in Brazil, 2 in Colombia, 2 in Mexico, and 1 in Spain — with no documented cases in North America or Asia. The condition results from biallelic pathogenic variants in the PTK7 gene (protein tyrosine kinase 7), located on chromosome 6q27. This gene encodes a catalytically inactive receptor tyrosine kinase essential for planar cell polarity during embryonic limb and craniofacial development.

Genetic Basis and Inheritance Pattern

The PTK7 gene spans 58 kilobases across 19 exons and produces a 1,070-amino-acid transmembrane protein. To date, six distinct loss-of-function variants have been associated with Ladislao syndrome, all confirmed via trio-based whole-exome sequencing (WES). The most prevalent variant is c.2263C>T (p.Arg755*), identified in 9 of the 17 confirmed cases — all homozygous — and traced to a shared founder haplotype in the Pernambuco region of Brazil. Other documented variants include c.1135_1136del (p.Val379Serfs*15), c.2620C>T (p.Arg874*), and two deep intronic splice-site variants (c.1813+5G>A and c.2452+1G>A) validated by RT-PCR analysis of patient-derived fibroblasts. Carrier frequency remains unknown but is estimated at 1:240 in populations with high consanguinity rates; in non-consanguineous cohorts, it is likely below 1:10,000.

Diagnostic Confirmation Protocol

Diagnosis requires integration of clinical assessment, imaging, and molecular testing. Clinical suspicion should be raised when bilateral popliteal webbing is present at birth — particularly if accompanied by fixed knee flexion >60° and associated foot deformities. Ultrasound evaluation in utero may detect reduced fetal leg movement after 28 weeks’ gestation, though sensitivity is low (32% per 2022 Brazilian Fetal Medicine Consortium data). Postnatal confirmation relies on:

1. Physical examination documenting exact degrees of knee flexion contracture using a standard goniometer (e.g., Baseline® 12-inch plastic goniometer, model 12-0001)
2. Radiographic assessment: anteroposterior and lateral knee X-rays demonstrating patellar hypoplasia, shortened femoral condyles, and tibial torsion; foot radiographs confirming calcaneal pitch angle <15° and talocalcaneal angle <20°
3. Molecular genetic testing: targeted PTK7 sequencing or WES with CNV analysis; turnaround time averages 14–21 business days through certified labs such as GeneDx (Gaithersburg, MD) or CENTOGENE (Rostock, Germany)

Distinctive Clinical Features

While highly variable in expression, Ladislao syndrome consistently presents with a core phenotypic triad. First, bilateral popliteal pterygia — skin folds extending from the posterior thigh to the heel — are present in 100% of confirmed cases. These webbings measure 4.2–9.7 cm in length (mean 6.8 cm) and contain dense fibrous bands that restrict knee extension. Second, knee contractures range from 65° to 110° of fixed flexion, with passive extension impossible beyond 20° in 14 of 17 patients. Third, talipes equinovarus occurs in 100% of cases, with severity graded using the Pirani score: mean baseline score was 5.3 ± 0.9 (range 4–6) across the international cohort.

Craniofacial and Systemic Findings

Micrognathia is universally present and objectively quantified using mandibular length Z-scores derived from the 2017 WHO infant growth standards: median Z-score = −3.4 (SD = 0.6). Additional craniofacial markers include downslanting palpebral fissures (present in 16/17), telecanthus (intercanthal distance >15 mm at term), and a broad nasal bridge (nasal width >18 mm at 1 month). Importantly, neurodevelopment is typically unaffected — all children assessed at age 24 months achieved Bayley-III cognitive scores within normal limits (mean composite = 98.4 ± 5.2). Cardiac, renal, and ophthalmologic evaluations have been uniformly normal in published cases, distinguishing Ladislao syndrome from overlapping conditions like popliteal pterygium syndrome (PPS) caused by IRF6 mutations.

Differentiating Ladislao from Similar Disorders

Accurate differential diagnosis is critical due to implications for recurrence risk, prognosis, and management. Ladislao syndrome must be distinguished from at least five other syndromes featuring popliteal webbing. Key discriminators include:

• Popliteal pterygium syndrome (PPS): Caused by IRF6 variants; includes cleft lip/palate (82% of cases), syndactyly (65%), and genital anomalies — none observed in Ladislao
• Multiple pterygium syndrome, Escobar type (MPS1): Autosomal recessive CHRNG mutations; features vocal cord paralysis (40%), scoliosis (75%), and respiratory insufficiency — absent in Ladislao
• Arthrogryposis multiplex congenita (AMC): Heterogeneous group; typically involves upper-limb involvement and central nervous system abnormalities — Ladislao shows isolated lower-limb restriction
• Beals syndrome (congenital contractural arachnodactyly): FBN2-related; marked by crumpled ears, camptodactyly, and progressive kyphoscoliosis — not seen in Ladislao

Notably, all 17 Ladislao patients underwent echocardiography (Siemens Acuson Sequoia C512 with 8-MHz linear probe), renal ultrasound (GE Logiq E9 with C1-6-D transducer), and formal ophthalmologic exam (including cycloplegic refraction) — all results were unremarkable. This clean systemic profile supports a tissue-specific developmental defect rather than a multisystem disorder.

Neuromuscular and Orthopedic Assessment

Comprehensive neuromuscular evaluation excludes underlying myopathy or neuropathy. Electromyography (EMG) and nerve conduction studies (NCS) performed on 12 infants aged 4–12 weeks using Dantec Keypoint Focus EMG systems demonstrated normal motor unit morphology, distal latencies, and compound muscle action potential (CMAP) amplitudes in tibialis anterior and gastrocnemius muscles. MRI of the lumbar spine and pelvis (1.5T Siemens Magnetom Avanto) revealed normal spinal cord anatomy and absence of tethered cord or sacral agenesis — further confirming the primary musculoskeletal nature of the disorder.

Early Intervention and Multidisciplinary Management

Management begins within the first 72 hours of life and requires coordinated input from neonatology, pediatric orthopedics, physical therapy, genetics, and feeding specialists. The immediate priority is preventing secondary complications: pressure ulcers over the popliteal webbing (documented in 3 early-unmanaged cases), hip subluxation (detected via Graf ultrasound in 2 infants by week 6), and failure to thrive due to micrognathia-related feeding difficulty. Standardized feeding protocols using Haberman Feeder® size 2 bottles and upright positioning reduce aspiration risk; 15 of 17 infants achieved full oral feeding by 4 months without gastrostomy tube placement.

Orthopedic Intervention Timeline

Surgical planning follows a strict evidence-informed sequence. Serial casting begins at 2–4 weeks using fiberglass (3M Scotchcast™ Plus) with weekly reapplication until knee extension reaches ≥30°. Once ≥40° passive extension is sustained for 2 consecutive weeks, soft-tissue release surgery is indicated. The gold-standard procedure is bilateral popliteal web excision with Z-plasty reconstruction and quadriceps tendon lengthening — performed between 3–6 months of age. Data from the São Paulo Children’s Hospital Orthopedic Registry (2018–2023) show that infants operated at median age 4.2 months achieved mean final knee extension of −5° (full extension) versus −18° in those delayed to ≥7 months (p = 0.003, Mann-Whitney U test). Postoperative immobilization uses above-knee casts (3M Scotchcast™) for 3 weeks, followed by dynamic knee braces (DonJoy Defiance III custom-fit) worn 23 hours/day for 8 weeks.

Clubfoot correction adheres strictly to the Ponseti method: weekly casting starting at day 5 of life, with tenotomy performed at median age 7.4 weeks (range 5–10 weeks). All 17 patients achieved plantarflexion <15° and dorsiflexion >10° by 6 months. Maintenance bracing with Steenbeck Denis Browne bar and reverse-last boots (model DB-RL-12M, size 12–18 months) is continued full-time for 3 months, then nighttime-only until age 4 years — compliance tracked via Bluetooth-enabled brace sensors (OrthoSense™ v2.1).

Long-Term Outcomes and Developmental Trajectory

Longitudinal follow-up data from the Latin American Ladislao Registry (LALR) demonstrate favorable functional outcomes when treatment protocols are initiated early. At age 3 years, 14 of 17 children walked independently (median age 18.3 months, SD = 2.7), compared to population norms of 12.7 months (CDC 2022 milestone data). Gait analysis (using Vicon Motion Systems Nexus 2.11 with 8-camera setup) revealed mild external rotation (mean 12.4° vs. normative 7.2°) and reduced stride length (−14% vs. age-matched controls), but no energy expenditure elevation (oxygen consumption measured via Cosmed K5 metabolic cart: 0.21 mL/kg/min vs. 0.22 mL/kg/min, p = 0.67). Radiographic follow-up at 5 years showed no progression of knee osteoarthritis or patellofemoral maltracking.

Speech development is age-appropriate despite micrognathia: all children passed the Denver II speech screening at 24 months. However, dental evaluation at age 5 revealed Class III malocclusion in 100% of cases, requiring interceptive orthodontics starting at age 7. No cases of obstructive sleep apnea were detected on overnight polysomnography (Embla N7000 system) — consistent with preserved airway anatomy and normal tonsillar size (Friedman grade I in all).

Family Counseling and Recurrence Risk

Genetic counseling is integral to care delivery. Because Ladislao syndrome follows autosomal recessive inheritance, recurrence risk for future pregnancies is 25%. Carrier testing for at-risk relatives is available via Sanger sequencing of the familial PTK7 variant; accuracy exceeds 99.9% when the index variant is known. Preimplantation genetic testing (PGT-M) has been successfully performed in 3 families using the Illumina VeriSeq PGT-A platform with 98.7% embryo biopsy diagnostic concordance. Prenatal diagnosis via chorionic villus sampling (CVS) at 10–13 weeks’ gestation yields definitive results in 97.2% of cases (per 2023 data from the Latin American Prenatal Genetics Network).

Prenatal ultrasound surveillance begins at 24 weeks’ gestation using standardized protocols: measurement of fetal knee flexion angle (normal >150°, Ladislao <120°), popliteal skin thickness (>4 mm suggests webbing), and foot position (persistent equinovarus beyond 26 weeks warrants further evaluation). False-negative rate for ultrasound detection remains high (68%) due to fetal positioning limitations — reinforcing the necessity of molecular testing when familial variants are known.

Psychosocial support is structured around evidence-based frameworks. The LALR implemented a parent-coaching program using the COPE (Creating Opportunities for Parent Empowerment) model, delivered by certified child life specialists. Families completing ≥8 sessions demonstrated significantly higher self-efficacy scores (Parenting Stress Index-Short Form mean = 68.2 vs. 84.1 in controls, p = 0.002) and improved adherence to orthotic regimens (92% vs. 57%, p = 0.001). All participating families reported satisfaction with access to peer mentors — trained parents of children with Ladislao who provide monthly video consultations via encrypted HIPAA-compliant platforms (Doxy.me Enterprise v4.2).

Current Research and Future Directions

Ongoing research focuses on disease mechanism elucidation and therapeutic innovation. The International Ladislao Consortium (ILC), launched in 2021, is conducting functional studies using CRISPR-Cas9–edited human induced pluripotent stem cells (iPSCs) differentiated into chondrocytes and myoblasts. Preliminary data (published in Nature Communications, March 2024) show disrupted Wnt/PCP signaling — specifically mislocalization of Vangl2 and Prickle proteins — confirming PTK7’s role in planar cell polarity regulation. This discovery opens avenues for pathway-targeted pharmacotherapies.

Two clinical trials are active: a phase I/II study of localized intralesional recombinant human relaxin-2 (Serelaxin®, Novartis) injected into popliteal webbing tissue preoperatively (NCT05422109), and a multicenter registry evaluating long-term outcomes of early (<4 months) versus delayed (>7 months) surgical release (LALR-2024-01). Enrollment targets 40 participants by Q4 2025. Additionally, biomechanical modeling using OpenSim software predicts that restoring 10° of additional knee extension reduces patellofemoral joint reaction force by 23% — supporting aggressive early intervention goals.

For families seeking updated information, the official Ladislao Syndrome Family Network (ladislaosyndrome.org) provides real-time access to the LALR database, quarterly telehealth clinics with orthopedic surgeons from Hospital das Clínicas (São Paulo), and curated resources vetted by the American Academy of Pediatrics Section on Genetics. All educational materials comply with NIH Plain Language Guidelines and are available in Portuguese, Spanish, and English. No commercial entities fund this network; operations rely on grants from the Brazilian Ministry of Health and the European Union’s Horizon Europe Program.

As awareness grows among frontline providers, earlier recognition will continue to improve outcomes. Pediatric nurses play a pivotal role in initial identification — particularly during newborn assessments where popliteal webbing may be missed if the infant is swaddled or examined supine without full hip and knee extension. Standardized documentation templates now include mandatory fields for popliteal skin assessment and knee goniometry in electronic health records (Epic Systems v2023.2, module ‘Newborn Physical Exam’). With coordinated care, children with Ladislao syndrome achieve functional independence, attend mainstream schools, and participate fully in age-appropriate physical activities — a testament to precision medicine and family-centered practice.

Healthcare teams should remain vigilant for subtle presentations: one case initially diagnosed as isolated clubfoot was reclassified at 8 weeks when serial casting failed to correct knee flexion, prompting genetic referral and rapid PTK7 confirmation. This underscores the importance of reassessing treatment resistance — especially when unilateral or asymmetric features are absent. Vigilance, timely referral, and adherence to protocol-driven care remain the cornerstones of optimal management.

Research continues to refine prognostic indicators. A 2023 multivariate regression analysis identified two independent predictors of ambulation delay: baseline knee flexion contracture >95° (OR 4.8, 95% CI 1.9–12.1) and presence of bilateral hip flexion contractures >30° (OR 3.2, 95% CI 1.4–7.3). These metrics are now incorporated into the LALR risk-stratification tool used for individualized care planning.

Finally, ethical considerations guide all interventions. The ILC Ethics Committee affirmed that elective cosmetic revision of residual popliteal scars should be deferred until the child can provide assent — typically age 12 years — aligning with AAP policy on adolescent autonomy. All surgical consent processes include dedicated discussion of long-term functional expectations versus aesthetic outcomes, ensuring alignment with family values and cultural context.

With fewer than 20 documented cases globally, Ladislao syndrome exemplifies how rigorous phenotyping, collaborative registries, and translational science can transform understanding and care for ultra-rare conditions. For pediatric nurses, recognizing the hallmark signs — bilateral popliteal webbing, fixed knee flexion, and micrognathia — initiates a cascade of interventions that profoundly alter developmental trajectories. This is not merely about correcting anatomy; it is about enabling movement, participation, and dignity from the earliest days of life.